More than $1.1 million has been invested by the Health Research Council of New Zealand (HRC) into three international health research collaborations.

These projects bring together New Zealand health researchers and international partners to investigate important health issues including approaches to treating melanoma, drug discovery in HIV-1 and the prevention of cerebral palsy.

The collaborations are funded through Objective 1 of the International Investment Opportunities Fund (IIOF), which focuses on enabling outstanding New Zealand researchers to build research collaborations with overseas research teams. The fund supports applicants to engage in research activities that will produce gains for New Zealand, offer significant leverage to build New Zealand's health research capacity, and are likely to attract international co-funding to support longer term research projects.

Each of the research proposals selected has the potential to benefit the health of New Zealanders.